Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Jacobson Pharma Corporation Limited ( (HK:2633) ) has issued an update.
Jacobson Pharma Corporation Limited announced the composition and roles of its board of directors and board committees, highlighting the leadership of Mr. Sum Kwong Yip, Derek as Chairman, CEO, and Executive Director. The announcement underscores the company’s governance structure, which includes committees focused on audit, remuneration, nomination, executive, and environmental, social, and governance matters, reflecting its commitment to comprehensive corporate governance.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, production, and distribution of pharmaceutical products, with a market presence indicated by its listing on the stock exchange under the code 2633.
Average Trading Volume: 1,246,367
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.19B
See more insights into 2633 stock on TipRanks’ Stock Analysis page.